Preclinical Assessment of HIV Vaccines and Microbicides by Repeated Low-Dose Virus Challenges

PLoS Medicine - United States
doi 10.1371/journal.pmed.0020249
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Zika Virus Vaccines: Challenges and Perspectives

Vaccines
Drug DiscoveryInfectious DiseasesImmunologyPharmacology
2018English

Vaginal Microbicides and the Prevention of HIV Transmission

The Lancet Infectious Diseases
Infectious Diseases
2008English

A Long-Acting Formulation of the Integrase Inhibitor Raltegravir Protects Humanized BLT Mice From Repeated High-Dose Vaginal HIV Challenges

Journal of Antimicrobial Chemotherapy
Infectious DiseasesMicrobiologyPharmacology
2016English

Introducing New Vaccines in Low and Middle-Income Countries: Challenges and Approaches

Expert Review of Vaccines
Molecular MedicineDrug DiscoveryImmunologyPharmacology
2019English

Single-Dose Attenuated Vesiculovax Vaccines Protect Primates Against Ebola Makona Virus

Nature
Multidisciplinary
2015English

Edible Vaccines: Promises and Challenges

Molecular Biotechnology
Applied MicrobiologyBiotechnologyMolecular BiologyBiochemistryBioengineering
2019English

Perspectives on Clinical and Preclinical Testing of New Tuberculosis Vaccines

Clinical Microbiology Reviews
ImmunologyEnvironmentalPublic HealthMicrobiologyMicrobiology EpidemiologyInfectious DiseasesOccupational Health
2010English

International Survey on High- And Low-Dose Synacthen Test and Assessment of Accuracy in Preparing Low-Dose Synacthen

Clinical Endocrinology
EndocrinologyMetabolismDiabetes
2018English

Therapeutic HIV Vaccines

Current Topics in Medicinal Chemistry
MedicineDrug Discovery
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy